by Michael Nace | May 24, 2019 | Genetic Counselors News, Just Published, Neurology News, News, Nursing News, Nutritionist News, Orthopedics News, Pediatricians News, Physical Therapists News, Pulmonologist News, Radiology News, Social Worker News, Urologists News
Zolgensma, a first gene therapy for spinal muscular atrophy — and first for any chronic neurologic disease — is now an approved and potential “one-time” intravenous treatment for pre-symptomatic newborns through 2-year-olds with any type of SMA, the U.S. Food and Drug...
by Michael Nace | Aug 15, 2018 | Genetic Counselor Resource Pages, Just Published, Neurologists Resource Pages, Nursing Resource Pages, Nutritionist Resource Page Three, Nutritionist Resource Pages, Orthopedics Resource Page Three, Orthopedics Resource Pages, Physical Therapists Resource Page Three, Physical Therapists Resource Pages, Pulmonologist Resource Pages, Social Worker Resource Page Two, Social Worker Resource Pages
Spinal Muscular Atrophy (SMA) is a congenital neuromuscular disorder characterized most prominently by progressive muscle atrophy and weakness.1 SMA is a neurodegenrative disease and the weakness and loss of muscle tone associated with SMA are the direct result...
by Michael Nace | Aug 15, 2018 | Genetic Counselor Resource Pages, Just Published, Neurologists Resource Pages, Nursing Resource Pages, Pulmonologist Resource Page Three, Pulmonologist Resource Pages, Social Worker Resource Page One, Social Worker Resource Pages, Urologist Resource Page Two, Urologist Resources
The disease course and prognosis of spinal muscular atrophy (SMA) depends heavily on the clinical classification in a particular patient. For example, the prognosis of children with SMA type 0 is very poor while the prognosis in SMA type 4 patients is relatively good....
by Michael Nace | Aug 15, 2018 | Genetic Counselor Resource Page Three, Genetic Counselor Resource Pages, Just Published, Neurologists Resource Pages, Pediatricians Resources
Spinal Muscular Atrophy (SMA) that presents after 6 months of age will include the second most common presentation of SMA, type 2 SMA, and the least commonly observed form of childhood onset SMA, type 3.1 The typical presenting symptoms of types 2 and 3 SMA,...
by Michael Nace | Aug 15, 2018 | Just Published, Neurologists Resource Page Two, Neurologists Resource Pages, Pediatricians Resources
Spinal Muscular Atrophy (SMA) types 0 and 1 should be considered in the differential diagnosis of every newborn and infant < 6 months old with hypotonia, hyporeflexia, tongue fasciculations, weakness, respiratory distress, or contractures.1 Other potential...
by Michael Nace | Aug 15, 2018 | Just Published, Nursing Resource Page Two, Nursing Resource Pages, Orthopedics Resource Page Two, Orthopedics Resource Pages, Pediatricians Resources, Pulmonologist Resource Page One, Pulmonologist Resource Pages
Children with spinal muscular atrophy (SMA) suffer from a number of orthopedic conditions. Scoliosis of the spine is quite common and is usually treated with bracing and/or instrumentation. However patients with SMA also experienced chest deformities that can lead to...
